Onesource Specialty Pharma Ltd
Ticker: ONESOURCE
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
1847.00
Market Cap
21152.81
Debt/Equity
0.1312
ROE %
-0.572
PB
3.5971
Promoter %
29.787
Pledge %
7.449
1Y Rev Growth %
730.156
5Y Rev Growth %
263.633
NP Margin %
-1.228
NP Margin 5Y Avg %
-574.000
Trading Reference
1M Return %
-1.346
6M Return %
17.823
1Y Return %
8.012
% Away 52W High
21.711
% Away 52W Low
52.651
Daily Volume
130227
Investment Verdict
Avoid
Score 41/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Onesource Specialty Pharma Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the recent resistance level, there is a strong potential for upward movement. However, if it falls below the support, it may face significant downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
C
CESC Ltd
CESC Ltd shows potential risks in growth and profitability, making it a risky investment at this time.
View details
P
PTC Industries Ltd
PTC Industries Ltd shows potential in a growing sector, but inconsistent financial performance and governance concerns pose significant risks.
View details
J
JSW Holdings Ltd
JSW Holdings Ltd shows potential for growth with a decent balance sheet and profitability metrics, but caution is advised due to some governance concerns and execution risks.
View details
S
Schneider Electric Infrastructure Ltd
Schneider Electric Infrastructure Ltd shows potential in a future-ready sector with decent growth prospects, but faces challenges in profitability and execution risks.
View details
E
eClerx Services Limited
eClerx Services Limited shows decent potential with consistent growth and a solid business model, but caution is advised due to some cash flow and governance concerns.
View details
S
Sagility Ltd
Sagility Ltd shows potential for growth, but investors should be cautious of execution risks and valuation metrics.
View details
S
Sarda Energy & Minerals Ltd
Sarda Energy & Minerals Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
C
CreditAccess Grameen Ltd
CreditAccess Grameen Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
P
Punjab & Sind Bank
Punjab & Sind Bank presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
N
Neuland Laboratories Ltd
Neuland Laboratories Ltd shows decent potential with consistent growth, but faces challenges in valuation and execution risks.
View details
A
Asahi India Glass Ltd
Asahi India Glass Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability and valuation metrics.
View details
A
Ather Energy Ltd
Ather Energy Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
M
Maharashtra Scooters Ltd
Maharashtra Scooters Ltd shows moderate potential with some strengths in governance and profitability, but faces challenges in growth consistency and market execution.
View details
P
Poly Medicure Ltd
Poly Medicure Ltd shows potential for growth with a decent financial profile, but investors should be cautious of execution risks and increasing competition.
View details
J
Jyoti CNC Automation Ltd
Jyoti CNC Automation Ltd shows decent potential with consistent growth, but faces challenges in execution and market competition.
View details
K
Karur Vysya Bank Ltd
Karur Vysya Bank shows potential but faces challenges in growth and execution, making it a cautious investment.
View details
Business Overview
Onesource Specialty Pharma Ltd is a leading Indian pharmaceutical company dedicated to providing specialized medications and healthcare solutions. Catering to healthcare professionals and patients alike, it focuses on delivering high-quality, innovative products that address unmet medical needs. With a commitment to excellence and patient care, Onesource plays a crucial role in enhancing health outcomes in India. Its robust pipeline and strategic partnerships position it as a key player in the specialty pharma sector.
- Leading provider of specialized medications
- Focus on high-quality and innovative healthcare solutions
- Addresses unmet medical needs in India
- Strong commitment to patient care and health outcomes
- Robust product pipeline and strategic partnerships
Investment Thesis
Onesource Specialty Pharma Ltd presents a compelling investment opportunity due to its strong promoter group, which enhances credibility and trust. The company's focus on digital services is poised for significant growth, positioning it well in a rapidly evolving market. Additionally, its attractive valuation compared to peers makes it an appealing choice for investors seeking long-term gains.
- Strong promoter group enhances credibility and strategic direction.
- Robust growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Focus on innovation and customer-centric solutions.
- Solid financial performance and growth trajectory.
Opportunity vs Risk
Opportunities
- Growing demand for specialty pharmaceuticals
- Potential for strategic partnerships
- Expansion into new markets
- Innovative product pipeline
- Strong management team
Risks ⚠️
- Regulatory hurdles in India
- High competition in sector
- Dependence on few key products
- Market volatility risks
- Supply chain disruptions
Peer Perspective
Onesource Specialty Pharma Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's. A sustained improvement in margins and consistent growth could trigger a rerating in its valuation.
Future Outlook
Onesource Specialty Pharma Ltd is well-positioned for growth, driven by its innovative pipeline. However, successful execution and stringent cost control will be crucial to fully capitalize on market opportunities.
AI FAQs for Retail Users
- Q: What does Onesource Specialty Pharma Ltd do?A: Onesource Specialty Pharma Ltd focuses on providing specialty pharmaceutical products and services.
- Q: Is Onesource Specialty Pharma Ltd a profitable company?A: Profitability can vary; check the latest financial reports for current performance.
- Q: What are the risks of investing in Onesource Specialty Pharma Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Onesource Specialty Pharma Ltd?A: Shares can be purchased through a stockbroker or an online trading platform.
- Q: Where can I find more information about Onesource Specialty Pharma Ltd?A: Refer to the company's official website and financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Onesource Specialty Pharma Ltd • Updated: 2025-09-18 00:40:20
-
10BusinessHighThe sector shows potential with increasing demand for specialty pharmaceuticals, but competition is intense.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow generation is below expectations.
-
8ValuationHighValuation metrics are higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Onesource Specialty Pharma Ltd shows potential in a growing sector, but faces challenges in execution and profitability. Caution is advised due to valuation concerns and market risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100